title: Stimulatory actions of lysophosphatidic acid on mouse ATDC5 chondroprogenitor cells.
abstract: Lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) are bioactive lysophospholipids that affect various cellular processes through G protein-coupled receptors. In our current study, we found by in situ hybridization that E11.5 mouse embryos strongly expressed the LPA receptor subtype LPA(1) in cartilaginous bone primordia and the surrounding mesenchymal cells. However, despite their wide-ranging actions, the roles of lysophospholipids in chondrogenesis remain poorly understood. The mouse clonal cell line ATDC5 undergoes a sequential differentiation of chondroprogenitor cells in vitro. Undifferentiated and differentiated ATDC5 cells express LPA(1) and other lysophospholipid receptors including S1P receptor S1P(1) and S1P(2). Taking advantage of this cell model, we studied the effects of LPA on the activities of chondroprogenitor cells. LPA markedly stimulates both DNA synthesis and the migration of ATDC5 chondroprogenitor cells in culture, whereas S1P suppresses the migration of these cells. Treatment with Ki16425, an LPA(1)- and LPA(3)-specific receptor antagonist, suppressed the fetal bovine serum-stimulated migration of ATDC5 cells by almost 80%. These results indicate that LPA plays an important role in the activation of chondroprogenitor cells.
authors.affiliation: Department of Cellular Differentiation, Institute for Frontier Medical Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan.
authors.forename: Ryota
authors.initials: R
authors.lastname: Itoh
authors.forename: Shigenori
authors.initials: S
authors.lastname: Miura
authors.forename: Aki
authors.initials: A
authors.lastname: Takimoto
authors.forename: Shunya
authors.initials: S
authors.lastname: Kondo
authors.forename: Hiroko
authors.initials: H
authors.lastname: Sano
authors.forename: Yuji
authors.initials: Y
authors.lastname: Hiraki
mesh_terms: D000818:Animals; D001842:Bone and Bones / Q000166:cytology / Q000196:embryology / Q000378:metabolism; D002460:Cell Line; D002464:Cell Migration Inhibition / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation; D019902:Chondrocytes / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D020219:Chondrogenesis / Q000187:drug effects; D004247:DNA / Q000096:biosynthesis; D004622:Embryo, Mammalian / Q000166:cytology / Q000378:metabolism; D017403:In Situ Hybridization; D007555:Isoxazoles / Q000494:pharmacology; D008246:Lysophospholipids / Q000378:metabolism*; D020935:MAP Kinase Signaling System; D051379:Mice; D008813:Mice, Inbred ICR; D011422:Propionates / Q000494:pharmacology; D020033:Protein Isoforms / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism; D034741:RNA, Small Interfering; D049368:Receptors, Lysophosphatidic Acid / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D049349:Receptors, Lysosphingolipid / Q000235:genetics / Q000378:metabolism; D013110:Sphingosine / Q000031:analogs & derivatives / Q000378:metabolism; D000081025:Sphingosine-1-Phosphate Receptors
chemical_list: C477898:3-(4-(4-((1-(2-chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acid; D007555:Isoxazoles; D008246:Lysophospholipids; D011422:Propionates; D020033:Protein Isoforms; D034741:RNA, Small Interfering; D049368:Receptors, Lysophosphatidic Acid; D049349:Receptors, Lysosphingolipid; C556330:S1pr1 protein, mouse; D000081025:Sphingosine-1-Phosphate Receptors; C533955:sphingosine-1-phosphate receptor-2, mouse; C060506:sphingosine 1-phosphate; D004247:DNA; D013110:Sphingosine
references.citation: Int Rev Cytol. 1995;159:265-358
references.pmid: 7737795
references.citation: J Cell Biochem. 2008 May 15;104(2):499-510
references.pmid: 18027882
references.citation: Stem Cells. 2008 Mar;26(3):789-97
references.pmid: 18065393
references.citation: Genomics. 2000 Mar 1;64(2):155-69
references.pmid: 10729222
references.citation: Nat Genet. 2008 Mar;40(3):329-34
references.pmid: 18297070
references.citation: Dev Biol. 2004 Jan 1;265(1):23-32
references.pmid: 14697350
references.citation: Pharmacol Ther. 2000 Nov;88(2):115-31
references.pmid: 11150592
references.citation: J Biol Chem. 2006 Sep 1;281(35):25822-30
references.pmid: 16829511
references.citation: Mol Cell Biol. 2006 Jul;26(13):5015-22
references.pmid: 16782887
references.citation: Eur J Biochem. 1992 May 15;206(1):217-24
references.pmid: 1587271
references.citation: Dev Biol. 2004 Apr 15;268(2):441-7
references.pmid: 15063179
references.citation: Eur J Biochem. 1989 Jan 15;179(1):71-8
references.pmid: 2465149
references.citation: Cell Differ Dev. 1990 May;30(2):109-16
references.pmid: 2201423
references.citation: J Cell Biol. 2002 Jul 22;158(2):227-33
references.pmid: 12119361
references.citation: Biochem Pharmacol. 2005 Dec 5;70(12):1764-71
references.pmid: 16242672
references.citation: Dev Dyn. 2007 Apr;236(4):1134-43
references.pmid: 17366625
references.citation: J Pharmacol Exp Ther. 2006 Aug;318(2):619-28
references.pmid: 16651401
references.citation: J Cell Biol. 1996 Apr;133(2):457-68
references.pmid: 8609176
references.citation: J Biol Chem. 2004 Apr 23;279(17):17634-9
references.pmid: 14744855
references.citation: J Biol Chem. 2006 Aug 18;281(33):23589-97
references.pmid: 16774927
references.citation: FEBS Lett. 2000 Mar 3;469(1):83-7
references.pmid: 10708761
references.citation: Trends Endocrinol Metab. 2007 Oct;18(8):300-7
references.pmid: 17904858
references.citation: J Biol Chem. 2009 Jun 26;284(26):17731-41
references.pmid: 19386608
references.citation: Mol Pharmacol. 2000 Dec;58(6):1188-96
references.pmid: 11093753
references.citation: J Biol Chem. 2003 Jul 11;278(28):25600-6
references.pmid: 12724320
references.citation: Biochem Biophys Res Commun. 2008 Jul 11;371(4):707-12
references.pmid: 18466763
references.citation: J Bone Miner Res. 1997 Aug;12(8):1174-88
references.pmid: 9258747
references.citation: Prog Lipid Res. 2003 Nov;42(6):498-526
references.pmid: 14559069
references.citation: Dev Biol. 2006 Jul 1;295(1):128-40
references.pmid: 16678811
references.citation: Mol Pharmacol. 2003 Oct;64(4):994-1005
references.pmid: 14500756
references.citation: Nature. 2003 May 15;423(6937):332-6
references.pmid: 12748651
references.citation: J Clin Invest. 2000 Oct;106(8):951-61
references.pmid: 11032855
references.citation: Nat Rev Mol Cell Biol. 2003 May;4(5):397-407
references.pmid: 12728273
references.citation: Bioessays. 2000 Feb;22(2):138-47
references.pmid: 10655033
references.citation: J Biol Chem. 2002 Jun 14;277(24):21197-206
references.pmid: 11929870
references.citation: Gene. 1999 Feb 4;227(1):89-99
references.pmid: 9931453
references.citation: J Cell Sci. 2001 Aug;114(Pt 15):2713-22
references.pmid: 11683406
references.citation: Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):13384-9
references.pmid: 11087877
references.citation: FEBS Lett. 2005 May 23;579(13):2919-25
references.pmid: 15890344
references.citation: J Biol Chem. 2002 Oct 18;277(42):39436-42
references.pmid: 12176993
references.citation: Biochem Biophys Res Commun. 2007 Nov 23;363(3):861-6
references.pmid: 17905198
references.citation: Cell. 1988 May 20;53(4):617-25
references.pmid: 2453291
references.citation: Nat Rev Cancer. 2003 Aug;3(8):582-91
references.pmid: 12894246
references.citation: Biochem J. 1993 May 1;291 ( Pt 3):677-80
references.pmid: 8489494
references.citation: Spine J. 2009 Apr;9(4):323-9
references.pmid: 18619909
references.citation: Anal Biochem. 1987 Apr;162(1):156-9
references.pmid: 2440339
references.citation: Mech Dev. 1999 Jun;84(1-2):121-5
references.pmid: 10473125